Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Cardiovascular prevention with glucose-lowering drugs in type 2 diabetes: An evidence-based approach to the categories of primary and secondary preventionDiabetes Obes Metab 2023 Aug 02;[EPub Ahead of Print], E Mannucci, GA Silverii
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.